Details on immune reconstitution of the 80 patients given haplo-HSCT, median (range)
| . | 1 mo . | 3 mo . | 6 mo . | 12 mo . |
|---|---|---|---|---|
| CD3+ T cells/μL | 231 (1-1618) | 254 (23-1472) | 668 (153-2596) | 1379 (407-3449) |
| CD4+ T cells/μL | 19 (0-442) | 89 (4-397) | 264 (87-1055) | 599 (174-1421) |
| CD8+ T cells/μL | 24 (0-910) | 96 (9-1108) | 301 (25-1581) | 574 (112-2301) |
| αβ T cells/μL | 47 (1-672) | 186 (12-1340) | 573 (135-2146) | 1291 (259-2795) |
| γδ T cells/μL | 181 (1-1335) | 49 (4-388) | 84 (4-752) | 94 (10-660) |
| CD3-CD56+ NK cells/μL | 236 (47-1813) | 196 (29-1448) | 283 (48-5441) | 269 (79-3116) |
| CD19+ B cells/μL | 0 (0-20) | 2 (0-473) | 160 (2-1609) | 291 (40-1616) |
| IgG, mg/dL | 973 (104-3153) | 580 (340-1041) | 597 (213-1487) | 711 (377-1351) |
| IgA, mg/dL | 32 (0-190) | 26 (0-186) | 33 (0-284) | 41 (0-221) |
| IgM, mg/dL | 10 (0-66) | 10 (0-44) | 47 (0-496) | 64 (0-469) |
| . | 1 mo . | 3 mo . | 6 mo . | 12 mo . |
|---|---|---|---|---|
| CD3+ T cells/μL | 231 (1-1618) | 254 (23-1472) | 668 (153-2596) | 1379 (407-3449) |
| CD4+ T cells/μL | 19 (0-442) | 89 (4-397) | 264 (87-1055) | 599 (174-1421) |
| CD8+ T cells/μL | 24 (0-910) | 96 (9-1108) | 301 (25-1581) | 574 (112-2301) |
| αβ T cells/μL | 47 (1-672) | 186 (12-1340) | 573 (135-2146) | 1291 (259-2795) |
| γδ T cells/μL | 181 (1-1335) | 49 (4-388) | 84 (4-752) | 94 (10-660) |
| CD3-CD56+ NK cells/μL | 236 (47-1813) | 196 (29-1448) | 283 (48-5441) | 269 (79-3116) |
| CD19+ B cells/μL | 0 (0-20) | 2 (0-473) | 160 (2-1609) | 291 (40-1616) |
| IgG, mg/dL | 973 (104-3153) | 580 (340-1041) | 597 (213-1487) | 711 (377-1351) |
| IgA, mg/dL | 32 (0-190) | 26 (0-186) | 33 (0-284) | 41 (0-221) |
| IgM, mg/dL | 10 (0-66) | 10 (0-44) | 47 (0-496) | 64 (0-469) |